Institutional investors purchased a net $381.2 thousand shares of RMD during the quarter ended December 2017 and now own 65.42% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 1.6 Million shares of ResMed Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 866.2 Thousand shares of ResMed Inc
RENAISSANCE TECHNOLOGIES LLC Bought 235.7 Thousand shares of ResMed Inc